Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public health good.

Peer-reviewed journals rejected their followup study on the 2023-2024 formulation of mRNA vaccines against the JN.1 variant ...

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

Shares of Novavax NVAX were down 19.6% on April 10 after the United States Health and Human Services (“HHS”) Secretary Robert ...

A tenet of virology is that you go after one of the proteins on the surface that generates a good immune response, and that’s what you target. This principle has withstood the test of time because ...